ReviewAnnals of medicine2021
The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection.
Emily Brown et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled itcites it
ReviewAnnals of medicine2021
Emily Brown et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.